慢性腰痛の世界市場レポート 2025年

慢性腰痛市場規模は、今後数年間で力強い成長が見込まれます。2029年には99億9,000万米ドルに成長し、CAGRは5.5%となります。予測期間の成長は、非薬理学的介入の増加、予防ヘルスケアへの取り組み、ホリスティック治療への注目、再生医療開発、高齢化傾向などに起因すると考えられます。予測期間の主な動向としては、非薬理学的介入への注目、疼痛管理アプローチの転換、ヘルスケア意識と教育、遠隔医療と遠隔モニタリング、再生医療の統合などが挙げられます。

慢性腰痛市場は、神経疾患の発生頻度の増加によって成長が見込まれています。この文脈では、ナーバスインスタンスとは、困難な状況において個人が勇気、勇気、回復力を示す特定の出来事を指します。ストレスや痛みに継続的にさらされると、中枢性感作を引き起こす可能性があります。中枢性感作とは、神経系が過敏になり、実際に傷がなくても痛みを強く感じるようになる現象です。2023年7月にNature誌が報告したように、神経の損傷を伴う末梢神経障害の有病率は、糖尿病のある40歳以上の成人で28.4％、糖尿病のない人では11.8％です。神経障害の頻度上昇は、慢性腰痛市場の成長に寄与しています。

老人人口の増加が、慢性腰痛市場の今後の成長を牽引すると予測されています。老人人口とは65歳以上の個人を指します。この層では、関節炎や変形性関節症などの加齢に関連した神経変性疾患や筋骨格系の疾患が急速に進行する傾向があり、その結果、筋力低下や痛みを伴う不定愁訴が生じ、慢性的な腰痛や身体活動の低下につながります。例えば、2024年5月、米国の政府機関である地域生活局（Administration for Community Living）は、2022年には人口の17.3％が65歳以上であったと報告しています。この割合は、2040年には22％に上昇すると予測されています。その結果、老人人口の増加が慢性腰痛市場の拡大に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界慢性腰痛PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の慢性腰痛市場：成長率分析
• 世界の慢性腰痛市場の実績：規模と成長, 2019-2024
• 世界の慢性腰痛市場の予測：規模と成長, 2024-2029, 2034F
• 世界慢性腰痛総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の慢性腰痛市場痛みの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 椎間板性疼痛
• 腰部脊椎管狭窄症
• 仙腸関節痛
• 椎間関節痛
• 神経根痛
• 筋肉痛
• その他の種類の痛み
• 世界の慢性腰痛市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床歴
• 身体検査
• イメージングガイドライン
• 痛みの評価
• 世界の慢性腰痛市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 整形外科クリニック
• 外来手術センター
• その他のエンドユーザー
• 世界の慢性腰痛市場椎間板性疼痛の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 椎間板ヘルニア
• 変性椎間板疾患
• 椎間板ヘルニア
• 腰部脊椎管狭窄症
• 世界の慢性腰痛市場、腰部脊柱管狭窄症のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 中心狭窄
• 側方狭窄
• 世界の慢性腰痛市場仙腸関節痛の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 仙腸関節機能障害
• 炎症性疾患
• 世界の慢性腰痛市場、椎間関節痛の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 椎間関節症候群
• 椎間関節の変形性関節症
• 世界の慢性腰痛市場、神経根性疼痛のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 坐骨神経痛
• 神経根の圧迫
• 世界の慢性腰痛市場筋肉痛の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 筋肉の緊張
• 筋けいれん
• 世界の慢性腰痛市場、その他の種類の痛みのサブセグメンテーション、種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 筋筋膜性疼痛症候群
• 脊椎すべり症
• 骨粗鬆症に伴う痛み

第7章 地域別・国別分析

• 世界の慢性腰痛市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の慢性腰痛市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性腰痛市場：競合情勢
• 慢性腰痛市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Endo Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis
  • Merck Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Vertebral Technologies Inc.
• Medtronic plc
• Boston Scientific Corporation
• BioWave Corporation
• Koninklijke Philips N.V.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• SpineThera Inc.
• Dr. Reddy's Laboratories Ltd.
• Celgene Corporation
• Axsome Therapeutics Inc.
• Mesoblast Limited
• Frontier Biotechnologies Inc.
• Eli Lilly and Company
• Persica Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 慢性腰痛市場2029：新たな機会を提供する国
• 慢性腰痛市場2029：新たな機会を提供するセグメント
• 慢性腰痛市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Chronic low back pain (CLBP) characterizes pain persisting for 12 weeks or more, despite treatment aimed at resolving the initial cause or acute episode of low back pain. This condition represents a major contributor to disability and often gives rise to psychological issues such as stress, depression, and anxiety.

The primary types of chronic lower back pain encompass discogenic pain, lumbar spinal stenosis, sacroiliac pain, facet-joint pain, radicular pain, muscular pain, and other variants. Discogenic pain specifically originates from damage to spinal discs, commonly associated with conditions such as degenerative disc disease, which occurs naturally as part of the aging process. Diagnosis typically involves a comprehensive clinical history, physical examination, imaging assessments, and pain evaluation. Treatment is administered across various healthcare facilities, including hospitals, orthopedic clinics, ambulatory surgery centers, among others.

The chronic lower back pain market research report is one of a series of new reports from The Business Research Company that provides chronic lower back pain market statistics, including chronic lower back pain industry global market size, regional shares, competitors with a chronic lower back pain market share, detailed chronic lower back pain market segments, market trends and opportunities, and any further data you may need to thrive in the chronic lower back pain industry. This chronic lower back pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic lower back pain market size has grown steadily in recent years. It will grow from $7.72 billion in 2024 to $8.08 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to sedentary lifestyles, manual labor and occupational risks, medical advancements in diagnosis, pain management evolution, epidemiological studies.

The chronic lower back pain market size is expected to see strong growth in the next few years. It will grow to $9.99 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in non-pharmacological interventions, preventive healthcare initiatives, focus on holistic treatments, regenerative medicine development, aging population trends. Major trends in the forecast period include focus on non-pharmacological interventions, shift in pain management approaches, healthcare awareness and education, telemedicine and remote monitoring, integration of regenerative medicine.

The chronic lower back pain market is expected to witness growth driven by an increase in the frequency of nerve instances. In this context, nerve instances refer to specific occurrences where individuals display bravery, courage, or resilience in challenging situations. Continuous exposure to stress and pain can lead to central sensitization, a phenomenon where the nervous system becomes hypersensitive, intensifying the perception of pain even in the absence of actual injury. As reported by Nature in July 2023, the prevalence of peripheral neuropathy, associated with nerve damage, is 28.4% in adults aged 40 or older with diabetes and 11.8% in those without diabetes. The rising frequency of nerve instances contributes to the growth of the chronic lower back pain market.

An increase in the geriatric population is projected to drive the growth of the chronic lower back pain market in the future. The geriatric population refers to individuals aged 65 and older. In this demographic, age-related neurodegenerative and musculoskeletal conditions, such as arthritis and osteoarthritis, tend to progress rapidly, resulting in weakness and painful complaints that contribute to chronic back pain and decreased physical activity. For example, in May 2024, the Administration for Community Living, a US-based government agency, reported that in 2022, 17.3% of the population was 65 or older. This percentage is anticipated to rise to 22% by 2040. Consequently, the growth of the geriatric population is fueling the expansion of the chronic lower back pain market.

Technological advancements emerge as a key trend gaining popularity in the chronic lower back pain market. Major companies within this market are actively involved in developing new and improved advanced technologies for the treatment and prevention of lower back pain to maintain their competitive positions. In December 2022, Abbott Laboratories, a US-based medical devices and healthcare company, introduced the Eterna spinal cord stimulation (SCS) device. Recognized as the world's smallest implantable, rechargeable spinal cord stimulator for treating chronic pain, the Eterna SCS device, featuring Abbott's low-dose BurstDR stimulation technology, has received approval from the US Food and Drug Administration (FDA). This technological innovation demonstrates the commitment of major companies to advancing the treatment options for chronic lower back pain.

Major companies in the chronic lower back pain market are actively engaged in the development of products incorporating advanced technologies, such as BurstDR SCS technology, to introduce innovative options for patients. BurstDR SCS technology is a proprietary therapy within the spinal cord stimulation (SCS) category, employing mild electrical pulses to modify pain signals during their transmission from the spinal cord to the brain. An illustration of this technological advancement is evident in the case of Abbott Laboratories, a prominent US-based medical device company. In May 2023, Abbott Laboratories received approval from the US Food and Drug Administration (FDA) for its Spinal Cord Stimulation (SCS) devices, which include the Proclaim SCS Family and Eterna SCS System specifically designed for treating chronic back pain. Abbott's SCS devices utilize the proprietary BurstDR stimulation waveform, offering a superior therapy that closely replicates the pathway of pain signals to the brain, effectively addressing the emotional aspects associated with pain. This stands in contrast to traditional tonic stimulation methods.

In November 2023, Boston Scientific, a US-based biotechnology engineering firm, acquired Relievant Medsystems, Inc. for $850 million. This acquisition strengthens Boston Scientific's portfolio in chronic pain management by integrating Relievant's Intracept intraosseous nerve ablation system, which is specifically designed to address vertebrogenic pain, a type of chronic lower back pain. Relievant Medsystems, Inc. is a US-based manufacturer of medical equipment.

Major companies operating in the chronic lower back pain market include Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy's Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

North America was the largest region in the chronic lower back pain market in 2024. The regions covered in the chronic lower back pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chronic lower back pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic low back pain market includes revenues earned by entities by providing low back pain treatment services such as pain management services, and neuropathic and nociceptive pain management. Establishments that provide long treatment plans and management services are included in this market. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Lower Back Pain Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic lower back pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic lower back pain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic lower back pain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Pain: Diskogenic Pain; Lumbar Spinal Stenosis; Sacroiliac Pain; Facet-Joint Pain; Radicular Pain; Muscular Pain; Other Types Of Pain
• 2) By Diagnosis: Clinical History; Physical Examination; Imaging Guidelines; Assessment Of Pain
• 3) By End-User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End-Users
• Subsegments:
• 1) By Diskogenic Pain: Herniated Disc; Degenerative Disc Disease; Disc Bulge; Lumbar Spinal Stenosis
• 2) By Lumbar Spinal Stenosis: Central Stenosis; Lateral Stenosis
• 3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction; Inflammatory Conditions
• 4) By Facet-Joint Pain: Facet Joint Syndrome; Osteoarthritis Of The Facet Joints
• 5) By Radicular Pain: Sciatica; Nerve Root Compression
• 6) By Muscular Pain: Muscle Strain; Muscle Spasm
• 7) By Other Types of Pain: Myofascial Pain Syndrome; Spondylolisthesis; Osteoporosis-Related Pain
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Private Limited; Sanofi S.A.; Endo Pharmaceuticals plc; Merck Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Lower Back Pain Market Characteristics

3. Chronic Lower Back Pain Market Trends And Strategies

4. Chronic Lower Back Pain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Chronic Lower Back Pain Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Lower Back Pain PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Lower Back Pain Market Growth Rate Analysis
• 5.4. Global Chronic Lower Back Pain Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Lower Back Pain Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Lower Back Pain Total Addressable Market (TAM)

6. Chronic Lower Back Pain Market Segmentation

• 6.1. Global Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diskogenic Pain
• Lumbar Spinal Stenosis
• Sacroiliac Pain
• Facet-Joint Pain
• Radicular Pain
• Muscular Pain
• Other Types Of Pain
• 6.2. Global Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical History
• Physical Examination
• Imaging Guidelines
• Assessment of Pain
• 6.3. Global Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Orthopaedic Clinics
• Ambulatory Surgery Centres
• Other End-Users
• 6.4. Global Chronic Lower Back Pain Market, Sub-Segmentation Of Diskogenic Pain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herniated Disc
• Degenerative Disc Disease
• Disc Bulge
• Lumbar Spinal Stenosis
• 6.5. Global Chronic Lower Back Pain Market, Sub-Segmentation Of Lumbar Spinal Stenosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Central Stenosis
• Lateral Stenosis
• 6.6. Global Chronic Lower Back Pain Market, Sub-Segmentation Of Sacroiliac Pain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sacroiliac Joint Dysfunction
• Inflammatory Conditions
• 6.7. Global Chronic Lower Back Pain Market, Sub-Segmentation Of Facet-Joint Pain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Facet Joint Syndrome
• Osteoarthritis Of The Facet Joints
• 6.8. Global Chronic Lower Back Pain Market, Sub-Segmentation Of Radicular Pain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sciatica
• Nerve Root Compression
• 6.9. Global Chronic Lower Back Pain Market, Sub-Segmentation Of Muscular Pain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Muscle Strain
• Muscle Spasm
• 6.10. Global Chronic Lower Back Pain Market, Sub-Segmentation Of Other Types Of Pain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myofascial Pain Syndrome
• Spondylolisthesis
• Osteoporosis-Related Pain

7. Chronic Lower Back Pain Market Regional And Country Analysis

• 7.1. Global Chronic Lower Back Pain Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Lower Back Pain Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Lower Back Pain Market

• 8.1. Asia-Pacific Chronic Lower Back Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Lower Back Pain Market

• 9.1. China Chronic Lower Back Pain Market Overview
• 9.2. China Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Lower Back Pain Market

• 10.1. India Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Lower Back Pain Market

• 11.1. Japan Chronic Lower Back Pain Market Overview
• 11.2. Japan Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Lower Back Pain Market

• 12.1. Australia Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Lower Back Pain Market

• 13.1. Indonesia Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Lower Back Pain Market

• 14.1. South Korea Chronic Lower Back Pain Market Overview
• 14.2. South Korea Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Lower Back Pain Market

• 15.1. Western Europe Chronic Lower Back Pain Market Overview
• 15.2. Western Europe Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Lower Back Pain Market

• 16.1. UK Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Lower Back Pain Market

• 17.1. Germany Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Lower Back Pain Market

• 18.1. France Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Lower Back Pain Market

• 19.1. Italy Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Lower Back Pain Market

• 20.1. Spain Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Lower Back Pain Market

• 21.1. Eastern Europe Chronic Lower Back Pain Market Overview
• 21.2. Eastern Europe Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Lower Back Pain Market

• 22.1. Russia Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Lower Back Pain Market

• 23.1. North America Chronic Lower Back Pain Market Overview
• 23.2. North America Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Lower Back Pain Market

• 24.1. USA Chronic Lower Back Pain Market Overview
• 24.2. USA Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Lower Back Pain Market

• 25.1. Canada Chronic Lower Back Pain Market Overview
• 25.2. Canada Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Lower Back Pain Market

• 26.1. South America Chronic Lower Back Pain Market Overview
• 26.2. South America Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Lower Back Pain Market

• 27.1. Brazil Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Lower Back Pain Market

• 28.1. Middle East Chronic Lower Back Pain Market Overview
• 28.2. Middle East Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Lower Back Pain Market

• 29.1. Africa Chronic Lower Back Pain Market Overview
• 29.2. Africa Chronic Lower Back Pain Market, Segmentation By Type of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Lower Back Pain Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Lower Back Pain Market Competitive Landscape And Company Profiles

• 30.1. Chronic Lower Back Pain Market Competitive Landscape
• 30.2. Chronic Lower Back Pain Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Endo Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Lower Back Pain Market Other Major And Innovative Companies

• 31.1. Vertebral Technologies Inc.
• 31.2. Medtronic plc
• 31.3. Boston Scientific Corporation
• 31.4. BioWave Corporation
• 31.5. Koninklijke Philips N.V.
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Astellas Pharma Inc.
• 31.8. SpineThera Inc.
• 31.9. Dr. Reddy's Laboratories Ltd.
• 31.10. Celgene Corporation
• 31.11. Axsome Therapeutics Inc.
• 31.12. Mesoblast Limited
• 31.13. Frontier Biotechnologies Inc.
• 31.14. Eli Lilly and Company
• 31.15. Persica Pharmaceuticals

32. Global Chronic Lower Back Pain Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Lower Back Pain Market

34. Recent Developments In The Chronic Lower Back Pain Market

35. Chronic Lower Back Pain Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Lower Back Pain Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Lower Back Pain Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Lower Back Pain Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer